TY - JOUR
T1 - Enteric bacterial flora and bacterial overgrowth syndrome
AU - Gregg, Clark R.
PY - 2002/10/1
Y1 - 2002/10/1
N2 - Under certain conditions, colonic bacterial flora can colonize the upper small bowel in concentrations sufficient to cause mucosal damage and malabsorption of nutrients, vitamin B12, and fat-soluble vitamins. This situation, known as small bowel bacterial overgrowth syndrome (SBBOS) may be an under-appreciated cause of malnutrition in elderly people. The diagnosis of SBBOS should be considered when patients with known or suspected predisposing conditions have symptoms or findings compatible with this syndrome. However, proof of small bowel bacterial overgrowth requires specialized testing that is not readily available. Moreover, disagreement persists as to how best to test definitively for this disease. Therefore, on a practical level and despite the potential drawbacks of such a decision, SBBOS is usually diagnosed when a compatible syndrome responds to an empirical trial of appropriate oral antibiotics. Improvements on this approach to SBBOS will be built on more widespread access to sensitive, specific, and less cumbersome testing than is currently available. This is a US government work. There are no restrictions on its use.
AB - Under certain conditions, colonic bacterial flora can colonize the upper small bowel in concentrations sufficient to cause mucosal damage and malabsorption of nutrients, vitamin B12, and fat-soluble vitamins. This situation, known as small bowel bacterial overgrowth syndrome (SBBOS) may be an under-appreciated cause of malnutrition in elderly people. The diagnosis of SBBOS should be considered when patients with known or suspected predisposing conditions have symptoms or findings compatible with this syndrome. However, proof of small bowel bacterial overgrowth requires specialized testing that is not readily available. Moreover, disagreement persists as to how best to test definitively for this disease. Therefore, on a practical level and despite the potential drawbacks of such a decision, SBBOS is usually diagnosed when a compatible syndrome responds to an empirical trial of appropriate oral antibiotics. Improvements on this approach to SBBOS will be built on more widespread access to sensitive, specific, and less cumbersome testing than is currently available. This is a US government work. There are no restrictions on its use.
UR - http://www.scopus.com/inward/record.url?scp=0036809273&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036809273&partnerID=8YFLogxK
M3 - Review article
C2 - 12462706
AN - SCOPUS:0036809273
SN - 1049-5118
VL - 13
SP - 200
EP - 209
JO - Seminars in Gastrointestinal Disease
JF - Seminars in Gastrointestinal Disease
IS - 4
ER -